Oberland Biotech GmbH, a biotechnology and nutritional food company operating internationally, today announced the successful completion of a CHF 2.5 million seed funding round through a convertible ...

While several major biotech companies are laying off employees by the hundreds, one is dropping billions in acquisitions.

Dallas‑based Colossal Biosciences, known for its woolly mammoth work, has announced its next de‑extinction effort—aiming to ...

Biotech CEO pay packages mostly increased in 2025, with Biogen's Christopher Viehbacher topping the list at $23.6 million in ...

Biotech mergers and acquisitions have reached $84 billion in early 2026, the fastest start since 2019, driven by looming patent expirations, strong cash reserves, and attractive valuations. Meanwhile, ...

Nearly 20 years ago, Gina Ford left Texas to continue her career in the biosciences. Ford, a pharmacist by training, spent 16 ...

Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout ...

BENGALURU: India’s first state-led Centre of Excellence for Space Technology was launched in Bengaluru on Friday, marking a ...

Global biotech mergers and acquisitions are on track for one of their biggest years ever, with $84 billion in deals announced in the first quarter of 2026. Large pharmaceutical companies are racing to ...

Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...

Arbutus Biopharma Corporation (NASDAQ:ABUS) is one of the best biotech penny stocks to buy in 2026. On March 23, Arbutus ...

Autolus Therapeutics plc (NASDAQ:AUTL) is also pioneering the use of CAR T-cells in autoimmune diseases; the LUMINA trial is ...